Standing Still? Only if Injury-In-Fact Is Tied to the Claims at Issue
IRONSOURCE LTD. v. DIGITAL TURBINE, INC. Before Moore, Lourie, and Reyna. Appeal from the Patent Trial and Appeal Board. Summary: An appellant seeking to establish Article III standing based...
Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its Transseptal Puncture Device received 510(k) clearance from the FDA. Transseptal puncture is designed to enable access to...
Veteran Ventures Capital Announces Investment in Hybron Technologies as Hybron Technologies Closes $25M Seed Round
Key Takeaways: Hybron Technologies, a U.S. based Manufacturing company focused on lightweight composites for aerospace and defense applications, closes an oversubscribed $25M seed round. The increased need for domestic production...
IP Implications of NRC’s Proposed New Fast Lane for Licensing Reactor Designs Previously Approved by DOE or DOD
Key Takeaway: The NRC’s proposed streamlined DOE/DOD reactor licensing pathway includes public disclosure obligations that can constitute prior art to later filed patent applications, and that raise potential inventorship issues,...
Federal Circuit Review | March 2026
Software Claims Failed Alice Step One Where Purported Improvements Were Not Claimed In Trustees Of Columbia University v. Gen Digital Inc., Appeal No. 24-1243, the Federal Circuit held that software claims...
PTAB Update | March 2026
PTAB to Rehear Ex Parte Baurin: Revisiting the Interplay of Obviousness-Type Double Patenting and Patent Term Adjustment After Cellect and Allergan Daniel M. Mittelstein & Michael L. Fuller The PTO...
Alistair McIntyre and Tom Cowan Explore Latest Section 101 Patent Eligibility Developments in Inventors Digest Article
In their recent Inventors Digest article, Knobbe Martens lawyers Alistair McIntyre and Tom Cowan examine key developments in Section 101 patent eligibility, and offer practical guidance for inventors navigating complex...
USPTO Introduces Pre-Order Papers for Patent Owners in Ex Parte Reexaminations
Key Takeaway: With the decline of inter partes review (IPR) proceedings and the significant increase in ex parte reexamination (EPR) proceedings, the U.S. Patent and Trademark Office (USPTO) is allowing...
One Battle After Another: Broad Institute Wins at PTAB in CRISPR Dispute
Key Takeaways: Interference proceedings, though increasingly rare, are heavily evidence-based and determine which party is the first inventor when two or more applicants claim the same patentable invention. Sometimes, an...
